Literature DB >> 3015050

Papillomavirus DNA in warts of immunosuppressed renal allograft recipients.

A Gassenmaier, P Fuchs, H Schell, H Pfister.   

Abstract

Renal allograft recipients were shown to have an increased incidence of warts and skin cancers. We examined 148 patients for evidence of wart virus infections and tested for papillomavirus types, which are known to be associated with human malignancies. Of the 148, 36 (24.3%) patients were afflicted with warts at the end of our study period, in contrast to 5 of 148 (3.3%) before transplantation. DNA from 16 different biopsies was extracted by phenol treatment for further virological studies. DNA of human papillomavirus (HPV) 2 was detected three times, DNA of HPV 4 and 10 twice, and DNA of HPV 3 and 16 once each by blot hybridization. One probe led to strong signals with HPV types previously found only in epidermodysplasia verruciformis patients. A correlation between histology and virus type existed in cases of HPV 2, 3, 4, and 10 infections.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3015050     DOI: 10.1007/bf00412927

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  27 in total

1.  Characteristics of the lesions and risk of malignant conversion associated with the type of human papillomavirus involved in epidermodysplasia verruciformis.

Authors:  G Orth; S Jablonska; M Jarzabek-Chorzelska; S Obalek; G Rzesa; M Favre; O Croissant
Journal:  Cancer Res       Date:  1979-03       Impact factor: 12.701

2.  Risk of cancer in renal-transplant recipients.

Authors:  R Hoover; J F Fraumeni
Journal:  Lancet       Date:  1973-07-14       Impact factor: 79.321

3.  Cutaneous complications in immunosuppressed renal homograft recipients.

Authors:  F C Koranda; E M Dehmel; G Kahn; I Penn
Journal:  JAMA       Date:  1974-07-22       Impact factor: 56.272

4.  Viral warts, herpes simplex and herpes zoster in patients with secondary immune deficiencies and neoplasms.

Authors:  W L Morison
Journal:  Br J Dermatol       Date:  1975-06       Impact factor: 9.302

5.  Biology and biochemistry of papillomaviruses.

Authors:  H Pfister
Journal:  Rev Physiol Biochem Pharmacol       Date:  1984       Impact factor: 5.545

6.  Demonstration of human papilloma virus type 2 DNA in Bowen's disease.

Authors:  H Pfister; E Haneke
Journal:  Arch Dermatol Res       Date:  1984       Impact factor: 3.017

7.  Extensive verrucosis in primary immunodeficiency diseases.

Authors:  N Barnett; H Mak; J A Winkelstein
Journal:  Arch Dermatol       Date:  1983-01

8.  Cyclosporine: five years' experience in cadaveric renal transplantation.

Authors:  R M Merion; D J White; S Thiru; D B Evans; R Y Calne
Journal:  N Engl J Med       Date:  1984-01-19       Impact factor: 91.245

9.  Warts in a pediatric renal transplant population.

Authors:  J R Ingelfinger; W E Grupe; M Topor; R H Levey
Journal:  Dermatologica       Date:  1977

10.  Correlation between human papillomavirus (HPV) type and histology of warts.

Authors:  G Gross; H Pfister; M Hagedorn; L Gissmann
Journal:  J Invest Dermatol       Date:  1982-02       Impact factor: 8.551

View more
  13 in total

1.  Evaluation of a novel multiplex human papillomavirus (HPV) genotyping assay for HPV types in skin warts.

Authors:  Markus Schmitt; Maurits N C de Koning; Just A H Eekhof; Wim G V Quint; Michael Pawlita
Journal:  J Clin Microbiol       Date:  2011-08-03       Impact factor: 5.948

2.  Demonstration of human papillomavirus DNA in two keratoacanthomas.

Authors:  H Pfister; A Gassenmaier; P G Fuchs
Journal:  Arch Dermatol Res       Date:  1986       Impact factor: 3.017

3.  Development of an in vivo infection model to study Mouse papillomavirus-1 (MmuPV1).

Authors:  Aayushi Uberoi; Satoshi Yoshida; Paul F Lambert
Journal:  J Virol Methods       Date:  2017-12-15       Impact factor: 2.014

4.  Human papillomavirus 25-related DNA in solitary keratoacanthoma.

Authors:  A Gassenmaier; H Pfister; O P Hornstein
Journal:  Arch Dermatol Res       Date:  1986       Impact factor: 3.017

5.  Evaluation of a novel broad-spectrum PCR-multiplex genotyping assay for identification of cutaneous wart-associated human papillomavirus types.

Authors:  Maurits N C de Koning; Jan ter Schegget; Just A H Eekhof; Marga Kamp; Bernhard Kleter; Jacobijn Gussekloo; Mariet C W Feltkamp; Jan Nico Bouwes Bavinck; Karin J Purdie; Christopher B Bunker; Charlotte M Proby; Rhonda Meys; Catherine A Harwood; Wim G V Quint
Journal:  J Clin Microbiol       Date:  2010-03-17       Impact factor: 5.948

6.  Prevalence of antibodies to human papillomavirus type 8 in human sera.

Authors:  G Steger; M Olszewsky; E Stockfleth; H Pfister
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

7.  Isolation and characterization of human papillomavirus type 6-specific T cells infiltrating genital warts.

Authors:  K Hong; C E Greer; N Ketter; G Van Nest; X Paliard
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

8.  Virus-like particles and capsomeres are potent vaccines against cutaneous alpha HPVs.

Authors:  Tilo Senger; Lysann Schädlich; Sonja Textor; Corinna Klein; Kristina M Michael; Christopher B Buck; Lutz Gissmann
Journal:  Vaccine       Date:  2009-12-08       Impact factor: 3.641

9.  Detection and typing of human papillomaviruses in mucosal and cutaneous biopsies from immunosuppressed and immunocompetent patients and patients with epidermodysplasia verruciformis: a unified diagnostic approach.

Authors:  T Surentheran; C A Harwood; P J Spink; A L Sinclair; I M Leigh; C M Proby; J M McGregor; J Breuer
Journal:  J Clin Pathol       Date:  1998-08       Impact factor: 3.411

10.  Nested PCR approach for detection and typing of epidermodysplasia verruciformis-associated human papillomavirus types in cutaneous cancers from renal transplant recipients.

Authors:  R J Berkhout; L M Tieben; H L Smits; J N Bavinck; B J Vermeer; J ter Schegget
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.